The electric vehicle giant has started turning Elon Musk's 100-gigawatt solar goal into an active U.S. manufacturing push by scouting multiple sites to make solar cells. The company is weighing an ...
A new security feature rolled out to select models of the latest iPhones and iPads this week will make it more difficult for law enforcement, spies, and malicious hackers to obtain a person’s precise ...
New simulator and computational tools generate realistic ‘virtual tissues’ and map cell-to-cell ‘conversations’ from spatial transcriptomics data, potentially accelerating AI-driven discoveries in ...
The development of humans and other animals unfolds gradually over time, with cells taking on specific roles and functions via a process called cell fate determination. The fate of individual cells, ...
Ridley Scott's inimitable 1979 sci-fi thriller, Alien, expertly ratchets up the tension by not having the titular alien show up on screen until roughly an hour into the film. Following in Scott's ...
A Texas teenager was rescued by her father after she was forced into a truck at knifepoint on Christmas Day, police said. Patrol deputies with the Montgomery County Sheriff's Office were called to an ...
TL;DR: 20th Century Fox reportedly greenlit a new Alien franchise game, potentially developed by Eidos Montreal, known for Deus Ex and Tomb Raider. This singleplayer horror-survival title emphasizes ...
At its annual Ecosystem Day on December 12, Hithium Energy Storage signaled a strategic improvement beyond conventional four-hour batteries, positioning long-duration storage as both a grid asset and ...
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager, ALETA-001 Preliminary findings include a ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build a standardized framework for ...
BOSTON — Nov. 20, 2025 — Ginkgo Bioworks (NYSE: DNA) today announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results